Periodic Reporting for period 1 - pepRu4PACT (Ruthenium Peptide Bioconjugates for Photoactivated Chemotherapy)

Conventional anticancer therapies suffer from severe side effects due to their lack of selectivity, often damaging healthy tissues alongside tumours. A promising strategy to overcome this limitation is photoactivated chemotherapy (PACT), in which prodrugs remain inactive until...